Further research is required to determine whether and how mucin glycosylation patterns may be disrupted in patients with IBS, and whether Giardia-induced glycan alterations may be responsible for increased intestinal permeability that may contribute to post-infectious disease manifestations. The gene discussed is MUC5AC; the disease is irritable bowel syndrome.